Loading stock data...

Alfavision Overseas (India) Limited

BSE: ALFAVIO

BSE
8.59 0.10 (1.18%)

Prev Close

8.49

Open Price

8.42

Volume

1,660

Today Low / High

8.42 / 8.99

52 WK Low / High

8.41 / 16.66

Range

8 - 9

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 8.59, reflecting a change of 0.1 (1.17786%). The expected target range on the BSE is 8 - 9. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

04 Jul 8.88 1.58%
03 Jul 9.50 -8.32%
02 Jul 8.99 -2.00%
01 Jul 8.52 2.93%
30 Jun 8.94 -4.70%
27 Jun 9.00 -5.44%
26 Jun 8.99 -1.33%
25 Jun 8.66 3.12%
24 Jun 8.95 -3.24%
23 Jun 8.60 0.58%
20 Jun 8.59 2.44%
19 Jun 9.75 -11.90%
18 Jun 10.15 -3.45%
17 Jun 9.99 -1.70%
16 Jun 9.80 1.33%

Alfavision Overseas (India) Limited Graph

Alfavision Overseas (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Alfavision Overseas (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 8.59, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 8.59 8.68 7.81 - 9.54
8.76 7.01 - 10.51
8.85 6.19 - 11.50
Bearish Scenario 8.59 8.50 7.65 - 9.35
8.42 6.73 - 10.10
8.33 5.83 - 10.83

Overview of Alfavision Overseas (India) Limited

ISIN

INE883B01027

Industry

Biotechnology

Vol.Avg

7,101

Market Cap

284,364,520

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

N/A

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of ALFAVIO

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-09-29 September 29, 22 0.05 0.05 2022-09-29 2022-10-30
2021-09-22 September 22, 21 0.02 0.2 2021-09-23 2021-10-30

Stock Rating Details for ALFAVIO

Metric Value Recommendation
Overall Rating C Sell
DCF Score 1 Strong Sell
ROE Score 3 Neutral
ROA Score 3 Neutral
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1.91 Cr 1.63 Cr 0.28 Cr 0.1458 0.00 Cr 0.00 Cr 0.11 Cr 0.12 Cr 0.04 0.16 Cr 0.0639
2024-03-31 3.13 Cr 2.08 Cr 1.05 Cr 0.3345 0.00 Cr 0.03 Cr 0.93 Cr 0.28 Cr 0.09 1.01 Cr 0.0884
2023-03-31 30.81 Cr 55.43 Cr 3.15 Cr 0.1022 0.00 Cr 0.07 Cr 2.29 Cr 0.68 Cr 0.22 2.28 Cr 0.0221
2022-03-31 181.57 Cr 175.72 Cr 5.85 Cr 0.0322 0.00 Cr 0.18 Cr 4.84 Cr 2.01 Cr 0.64 6.16 Cr 0.0111
2021-03-31 179.10 Cr 173.35 Cr 5.74 Cr 0.0321 0.00 Cr 0.09 Cr 3.96 Cr 1.49 Cr 0.47 4.93 Cr 0.0083

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.08 Cr 178.93 Cr 136.84 Cr 42.0926 Cr 135.66 Cr 135.58 Cr 0.00 Cr 30.23 Cr 0.00 Cr 0.00 Cr 120.97 Cr 1.1189 Cr
2024-03-31 0.17 Cr 178.56 Cr 136.59 Cr 41.9709 Cr 124.36 Cr 124.19 Cr 0.00 Cr 30.27 Cr 0.00 Cr 0.00 Cr 0.62 Cr 0.8783 Cr
2023-03-31 0.13 Cr 204.84 Cr 161.56 Cr 43.2760 Cr 156.53 Cr 156.40 Cr 4.93 Cr 30.35 Cr 1.09 Cr 0.00 Cr 0.00 Cr 5.0447 Cr
2022-03-31 0.91 Cr 316.88 Cr 271.27 Cr 45.6012 Cr 143.15 Cr 142.24 Cr 1.05 Cr 30.38 Cr 0.05 Cr 0.00 Cr 104.09 Cr 142.0078 Cr
2021-03-31 0.21 Cr 115.44 Cr 101.92 Cr 13.5136 Cr 54.72 Cr 54.52 Cr 0.58 Cr 0.48 Cr 1.50 Cr 0.00 Cr 9.02 Cr 77.6370 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2024-03-31 -9.7203 Cr 1.1312 Cr 8.6426 Cr -9.7251 Cr 0.0535 Cr 0.1705 Cr 0.0000 Cr 0.2764 Cr 9.3420 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 2.5515 Cr -16.0073 Cr 12.6783 Cr 2.5325 Cr -0.7775 Cr 0.1330 Cr -0.0190 Cr -2.1531 Cr 15.6156 Cr -0.1634 Cr 1.0461 Cr
2022-03-31 -2.7054 Cr -81.7441 Cr 85.1528 Cr -2.7054 Cr 0.7033 Cr 0.9105 Cr 0.0000 Cr 2.1290 Cr 89.0728 Cr 0.0000 Cr -0.4633 Cr
2021-03-31 -2.6288 Cr -0.1726 Cr 2.4290 Cr -2.8028 Cr -0.3724 Cr 0.2072 Cr -0.1740 Cr 1.6925 Cr 5.5711 Cr 0.0000 Cr -0.5827 Cr
2020-03-31 -16.9856 Cr 0.4188 Cr 16.8048 Cr -17.0557 Cr 0.2380 Cr 0.5796 Cr -0.0701 Cr 0.2595 Cr 19.7894 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 -0.08 Cr -0.08 Cr -0.03 -0.07 Cr 0.0000
2024-12-31 0.49 Cr 0.44 Cr 0.05 Cr 0.1096 0.00 Cr 0.01 Cr 0.00 0.02 Cr 0.0252
2024-09-30 0.44 Cr 0.27 Cr 0.18 Cr 0.4023 0.12 Cr 0.12 Cr 0.04 0.13 Cr 0.2735
2024-06-30 0.97 Cr 0.83 Cr 0.17 Cr 0.1734 0.09 Cr 0.09 Cr 0.03 0.10 Cr 0.0892
2024-03-31 0.11 Cr 0.89 Cr -0.52 Cr -4.9525 -0.71 Cr 0.10 Cr 0.03 -0.65 Cr 0.9696

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.08 Cr 0.24 Cr 0.32 Cr 27.36 Cr 0.00 Cr 27.68 Cr 30.23 Cr 178.93 Cr 136.84 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -42.18 Cr
2024-09-30 0.17 Cr 0.24 Cr 0.40 Cr 0.00 Cr 0.00 Cr 27.63 Cr 30.25 Cr 178.89 Cr 136.71 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.17 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -41.97 Cr
2024-03-31 0.17 Cr 0.00 Cr 0.17 Cr 27.12 Cr 0.00 Cr 27.29 Cr 30.27 Cr 178.56 Cr 136.59 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 -0.59 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.02 Cr 0.25 Cr 0.23 Cr 0.00 Cr 0.02 Cr

Splits History

Date Label Split Ratio
2022-08-29 August 29, 22 10:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹379.10 ₹505,879,788,870.00 ₹5,647,219.00
Piramal Pharma Limited PPLPHARMA ₹207.88 ₹276,324,115,816.00 ₹11,733,063.00
Syngene International Limited SYNGENE ₹636.30 ₹255,673,184,943.00 ₹1,489,745.00
Concord Biotech Limited CONCORDBIO ₹1,836.80 ₹192,159,036,160.00 ₹183,480.00
Blue Jet Healthcare Limited BLUEJET ₹953.75 ₹165,442,644,325.00 ₹690,819.00
Jubilant Ingrevia Limited JUBLINGREA ₹807.45 ₹128,611,443,450.00 ₹353,633.00
Supriya Lifescience Limited SUPRIYA ₹714.85 ₹57,533,129,580.00 ₹229,992.00
Dishman Carbogen Amcis Limited DCAL ₹249.75 ₹39,156,554,250.00 ₹121,097.00
Zota Health Care Limited ZOTA ₹1,216.30 ₹35,284,128,355.00 ₹123,972.00
Panacea Biotec Limited PANACEABIO ₹425.25 ₹26,046,860,175.00 ₹195,931.00

Key Executives

Chairman & MD
Mr. Vishnu Prasad Goyal

Gender: male

Year Born: 1965

Chief Financial Officer & Non-Executive Director
Mr. Ravi Goyal

Gender: male

Year Born: 1991

Company Secretary & Compliance Officer
Mr. Devi Dayal

Gender: male

Year Born:

FAQs about Alfavision Overseas (India) Limited

Who is the CEO of the company?

The CEO is Vishnu Prasad Goyal.

What is the current market price of the stock?

The current price is ₹9.02.

What is the 52-week price range?

The range is ₹8.5-16.66.

What is the market capitalization of the company?

The market capitalization is ₹28.44 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 206.96.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Alfavision Overseas (India) Limited (ISIN: INE883B01027) is a leading Biotechnology in India. With a market capitalization of ₹28.44 crores and an average daily volume of 7,101 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack